|Day Low/High||337.29 / 357.64|
|52 Wk Low/High||102.66 / 497.49|
I could be wrong, but as far as I can tell, nobody else is telling the story about the sudden movement in these yields.
The whole notion of the grand inquisitor Fed is out of whack with reality. Here's what you should be watching, instead.
The fiscal football remains a greater threat this week than anything Fed Chair Jerome Powell says on Zoom this Friday.
Investors come into this week with 'all eyes' on the Kansas City Fed's economic symposium come week's end.
Watch Medigen stock, as the Taiwanese president becomes one of the first citizens of the island nation to roll up her sleeve.
Plus, checking out trades related to Amazon, Macy's and a few defense and metals stocks.
We just got hit with a two-by-four, but in your daze, don't confuse this retailer's report with the entire market and economy.
The tables have turned, their stocks have been up, and I think they go higher still.
A wall of liquidity seems to absorb every dip. But there are also enough reasons to be ever vigilant.
The negative economic impacts from the spread of the Delta variant of the SARS-CoV-2 virus are becoming apparent everywhere.
Sometimes it's best to move to the sidelines until something changes.
Plus, a look at what's going on inside the trader's brain as he looks at Walt Disney, Airbnb and SoFi Technologies.
Like Moderna , Nvidia , or AMD today, several months ago Micron was everyone's darling stock. In April, 2021, the shares traded at $96. Early in the year Fin TV and the guests paraded on those platforms gushed with optimism about MU - after all th...
These guys are aware that the U.S. was energy independent less than a year and a half ago, right?
One thing we know is that the current wave of the pandemic just seems to be getting worse.
The shares are only trading at 17 times forward earnings, and might not be fully valued just yet.
Imagine if the SEC did not prohibit underwriters from lending out shares to short-sellers for 30 days after an IPO?
The Delta virus has more power to control both fiscal and monetary policy than does the data or do any of our leaders individually.
Doesn't the Fed now have to taper asset purchases simply to avoid becoming an even greater force in these markets?
The charts of the vaccine maker indicate it's a good time to take some profits or raise stops, or both.
But remember I think it's all a snag and one that will be rectified in two ways.
Small-caps and mid-caps are still picking first downs on every play, storming back from a badly oversold condition that has just about normalized.
Also, there's reason to turn J&J's one shot jab into a two shot vaccine just like the rest.
In many respects, the Monday's action was a rerun of the standard COVID trade.
Those rattles you hear on the COVID, Fed and political fronts are reasons to tread carefully in the markets.
Here's how the U.S. can play a critical part in defending the island from COVID -- and mainland China.
Moderna has been a winner, but here's why traders should raise stops.
These companies were counted out way too early in the post-pandemic environment and the sellers are experiencing some real regret.
The greenback has maintained a higher level of relative strength versus its peer reserve currencies than I would have thought.
There's a split growing at the FOMC as to just how transitory the current burst of consumer level inflation actually is.